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Abstract
Kenya recently transitioned from a paper to an electronic system for recording and reporting of 
tuberculosis (TB) data. During September–October 2013, the data quality of the new system was 
evaluated through an audit of data in paper source documents and in the national electronic 
system, and an analysis of all 99,281 cases reported in 2012. While the new electronic system 
overall is robust, this assessment demonstrated limitations in the concordance and completeness of 
data reaching the national level. Additional oversight and training in data entry are needed to 
strengthen TB surveillance data quality in Kenya.
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Introduction
Kenya is one of the 22 high TB burden countries worldwide as classified by the World 
Health Organization (WHO), with an estimated annual incidence of 272 cases per 100,000 
persons1. In 2012, almost 100,000 new and relapse cases were reported nationally.
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A major objective of the Stop TB Strategy is the enhancement of high-quality DOTS 
programs2. To achieve this objective, WHO recommends establishing and maintaining well-
developed monitoring and evaluation systems within national TB programs. Compared to 
paper systems, electronic recording and reporting systems can strengthen data quality 
through automated validation checks, accelerate the availability of data for managers and 
decision-makers, and facilitate the analysis of local and national trends to monitor progress 
in TB control3.
In 2012, the Division of Leprosy, Tuberculosis and Lung Disease, Ministry of Health, Kenya 
underwent the transition from a paper-based recording and reporting system to an electronic 
system called Treatment Information from Basic Unit, or TIBU4. TIBU is a national case-
based surveillance system that stores details on individual patient episodes of TB reported to 
the national TB program. It includes patient locating information, demographic 
characteristics, clinical details, laboratory results, and treatment outcome data. TIBU has had 
nationwide coverage since 20125.
The flow of information in the surveillance system is based on a hierarchical reporting 
structure6. At the facility level (e.g. dispensaries, clinics, and hospitals), health workers 
record key data on TB patient cards, which are then transcribed into TB facility registers. 
During monthly visits to patient-care sites in jurisdictions called TB reporting zones, TB 
coordinators electronically transcribe data from TB registers using tablet computers 
provided by the national TB program. The tablet computers connect to the internet through 
Kenya’s mobile data network and automatically transmit encrypted case-based data in real-
time to a password-protected national server. TIBU data can be reviewed by TB coordinators 
to improve local case management and by staff at the national TB program for population-
level review and analysis.
To help inform the national TB program’s ongoing efforts to improve the new electronic 
system, we conducted a review of data captured by TIBU by analyzing concordance 
between source documents at TB facilities and TIBU, and by measuring the completeness of 
data transcribed from TB facility registers to TIBU for all cases registered in 2012.
Methods
For analysis of concordance, we visited two facilities from each of six randomly selected TB 
reporting zones located in four provinces near Nairobi. In total, 5 hospitals, 4 health centers, 
and 3 dispensaries/clinics were visited, with an average of 129 (range 6 – 311) cases per 
facility. All cases recorded in TB facility registers in the first quarter of 2012 were reviewed. 
Data for these cases in TB facility registers and corresponding TB patient cards were 
assessed for concordance with data in TIBU using Fleiss' Kappa coefficient. Calculation of 
concordance accounted for data recorded in one source and not recorded in another.
To assess completeness, 99,281 cases registered nationwide for treatment in 2012 and 
recorded in TIBU were reviewed. The case reports were de-identified and provided in 
electronic format by the national tuberculosis program. Completeness for key data items 
were calculated using proportions.
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CDC and the Kenya Ministry of Health both reviewed and approved this activity and 
determined that it was part of routine program evaluation and not human subjects research.
Results
Of the 222 cases reviewed from TB facility registers, 44 (20%) were located at dispensaries/
clinics, 80 (36%) at health centers, and 98 (44%) at hospitals. Only 152 (69%) cases had a 
corresponding TB patient card at the site of care delivery, and 219 (99%) were present in 
TIBU. Of 70 cases with missing TB patients cards, 50 (71%) were located at hospitals, 16 
(23%) at health centers, and 4 (6%) at dispensaries/clinics.
Table 1 demonstrates that the patient cards and the registers were mostly concordant, with 
kappa scores above 0.60 for most variables. The concordance between the registers and 
TIBU was better than that between TB patient cards and TIBU, although the district 
registration number and the registration date had kappa scores below 0.40.
A review of the completeness of the national 2012 data showed mixed results. Over 99% of 
cases had complete fields for treatment start date, age, sex, type of TB patient, site of 
disease, and initial sputum smear result. However, a high percentage of cases had blank 
values for HIV test date (47%), treatment regimen (12%), and treatment outcome date 
(30%).
Discussion
Kenya is the first country in East Africa to implement a national case-based electronic 
surveillance system for tuberculosis, permitting quicker reporting and analysis compared to 
a paper-based system. Making the transition from paper to electronic recording and 
reporting is complex, requiring an advanced information technology infrastructure and 
significant investment in human resources3. However, the improved timeliness of TIBU is 
counterbalanced by limitations in data quality. A successful rollout of a nationwide 
electronic surveillance system should be accompanied by routine review of data and regular 
feedback to users to improve the quality of data captured by the system.
Data in TB facility registers had higher concordance with TIBU than TB treatment cards, 
which is consistent with the practice of using TB facility registers as the primary record for 
documenting the treatment course of TB patients. Several variables had marginally higher 
concordance for TIBU and TB treatment cards compared to TIBU and TB facility registers. 
This result may be due to errors in transcription from treatment cards to the facility register 
that are corrected on entry into TIBU. The proportion of missing TB patient cards was 
highest among health centers and hospitals, suggesting that higher-level health facilities 
could benefit from training on record-keeping. The low concordance of district registration 
numbers and registration dates between TB facility registers and TIBU suggests a systematic 
error in the transcription of these variables. Regular data audits and data validation rules can 
detect and minimize these types of systematic errors.
This evaluation demonstrated two major implications of using TIBU for TB surveillance in 
Kenya. First, the suboptimal completeness and concordance of data may hinder informed 
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decision-making at the national level and may present challenges in using TIBU data to 
facilitate case management by TB district coordinators. Second, some cases from TB facility 
registers were not found in TIBU, suggesting that some reports were not transcribed to 
TIBU or were transcribed inaccurately. A nationwide inventory study is needed to better 
understand the extent of underreporting7.
Because the modest number of facilities that were evaluated might not be representative, 
results may not reflect TIBU’s concordance with source documents nationwide. 
Additionally, the study could not assess concordance stratified by facility type. Although the 
evaluation found aspects of TIBU that should be strengthened, the completeness and 
concordance of TIBU are comparable to findings from an evaluation of a well-established 
electronic tuberculosis reporting system (ETR.Net) in South Africa8.
Electronic recording and reporting systems can greatly improve the efficiency of data 
collection, aggregation, and analysis for national TB programs. With TIBU, Kenya has 
demonstrated that a robust electronic surveillance system can be used successfully for 
disease surveillance in a resource-limited setting. Countries seeking to implement electronic 
surveillance systems to monitor and evaluate disease trends should establish mechanisms to 
regularly evaluate data quality and provide feedback to users in order to optimize impact on 
TB control and prevention.
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• Kenya Ministry of Health recently deployed a case-based national 
electronic surveillance system for tuberculosis.
• Overall the new electronic surveillance system is robust but 
improvement in concordance and completeness of data is needed.
• Additional oversight and training in data entry and record management 
may strengthen TB surveillance data quality in Kenya.
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Table 1
Concordance of key variables from TB Patient Card, TB Facility Register, and Treatment Information from 
Basic Unit (TIBU), κ coefficient*
Concordance with TB
Patient Card (n = 152)
Concordance with TB
Facility Register (n = 222)
Category Variable TB FacilityRegister TIBU TIBU
Demographic District registration number 0.81 0.26 0.27
Age 0.95 0.91 0.96
Sex 0.93 0.91 0.97
Clinical Registration date - - 0.21
Type of tuberculosis 0.83 0.86 0.95
Type of patient 0.58 0.60 0.76
HIV status 0.64 0.57 0.79
ART 0.57 0.54 0.85
CPT 0.75 0.75 0.94
Bacteriology Sputum at 0 months 0.77 0.66 0.74
Sputum at 2/3 month 0.84 0.58 0.64
Sputum at 6 months 0.87 0.46 0.51
Sputum at 8 months 0.74 0.47 0.612
Drug susceptibility Culture 0.71 0.63 0.77
Treatment Treatment start date 0.81 0.59 0.65
Treatment outcome 0.13 0.16 0.68
Treatment end date 0.63 0.39 0.48
Treatment data Referred by 0.27 0.30 0.78
Referred to 0.44 0.26 0.50
Nutrition support 0.01 −0.13 0.40
DOT provider 0.23 0.22 0.54
*
κ values range from 1 to −1, with a value of 1 indicating 100% agreement between sources, a value of 0 indicating no agreement beyond what one 
would expect by chance, and a value of −1 indicating 100% disagreement. A value of 0.8–1.0 can be considered almost perfect agreement, 0.6– 0.8 
reflects substantial agreement, 0.4– 0.6 moderate agreement, 0.2– 0.4 fair agreement, 0– 0.2 slight agreement, and <0 reflects poor agreement.
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